• Navigation überspringen
  • Zur Navigation
  • Zum Seitenende
Organisationsmenü öffnen Organisationsmenü schließen
The Erlangen Vesicle Initiative
  • FAUZur zentralen FAU Website
  1. Friedrich-Alexander-Universität
  2. Medizinische Fakultät
  3. Institut für Anatomie
Suche öffnen
  • Impressum
  • Datenschutz
  • Barrierefreiheit
  1. Friedrich-Alexander-Universität
  2. Medizinische Fakultät
  3. Institut für Anatomie

The Erlangen Vesicle Initiative

Menu Menu schließen
  • About EVI
  • Events
    • Jour Fixe
    • Public Events
    Portal Events
  • Research Groups
    • Günther Lab
    • Reutter/Hilger/Mulzer Lab
    • Müller-Deile Lab
    • Arnold Lab
    • Vilhena Lab
    • Zunke Lab
    • Baur/Van Deun Lab
    • PROCARS Lab
    • Müller Lab
    • Fuhrmann Lab
    • Xiang Lab
    • Mattner Lab
    Portal Research Groups
  • GSEV Homepage
  • Contact
  1. Startseite
  2. Research Groups
  3. Fuhrmann Lab

Fuhrmann Lab

Bereichsnavigation: Research Groups
  • Günther Lab
  • Reutter/Hilger/Mulzer Lab
  • Müller-Deile Lab
  • Arnold Lab
  • Vilhena Lab
  • Zunke Lab
  • Baur/Van Deun Lab
  • PROCARS Lab
  • Müller Lab
  • Fuhrmann Lab
  • Xiang Lab
  • Mattner Lab

Fuhrmann Lab

Biogenic therapies for infection and inflammation

We are isolating and characterizing extracellular vesicles from bacteria, human cells and plant cultures. Our group is interested in understanding their pathophysiological role during infection and inflammation, but also their applicability as vehicles for antimicrobial compounds and vaccines. We provide a broad tool-set of loading and functionalization techniques, such as incorporation of drugs and model compounds, and surface functionalization with various ligands. We also combine inherent vesicle characteristics with novel biomaterial development.

 

Principal Investigator:

Prof. Dr. Gregor Fuhrmann

Prof. Dr. Gregor Fuhrmann

Professor of Pharmaceutical Biology

Friedrich-Alexander-Universität
Erlangen-Nürnberg

Schlossplatz 4
91054 Erlangen
  • Impressum
  • Datenschutz
  • Barrierefreiheit
  • BlueSky
  • Facebook
  • RSS Feed
  • Xing
  • YouTube
Nach oben